Shares of Ironwood Pharmaceuticals Inc. (IRWD) have lost a whopping 74% from their 52-week high of $15.70, recorded in February of this year, and trade around $4.
The company is anticipating an update on CNP-104 this quarter. This update could potentially influence IRWD's stock performance.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com